HHS Inspector General Meets With PBMs; Medco Explains “Transparency”
Executive Summary
The HHS Office of the Inspector General is seeking to gain a better understanding of the pharmacy benefit management industry in advance of the Medicare prescription drug program
You may also be interested in...
HHS’ Corrigan joins Arnold & Porter
Former Acting HHS Inspector General Dara Corrigan joins Arnold & Porter as co-head, along with William Vodra, of the firm's drug and medical device practice group in the U.S. Corrigan was part of the Office of Inspector General's initial meetings with PBMs to learn more about their business practices in advance of the Medicare drug benefit (1"The Pink Sheet" March 29, 2004, p. 15). Corrigan had been the Centers for Medicare & Medicaid Services director of program integrity before moving to HHS' OIG to fill in after the resignation of Janet Rehnquist in 2003. General Services Administration Inspector General Daniel Levinson was tapped as permanent HHS IG in July...
HHS’ Corrigan joins Arnold & Porter
Former Acting HHS Inspector General Dara Corrigan joins Arnold & Porter as co-head, along with William Vodra, of the firm's drug and medical device practice group in the U.S. Corrigan was part of the Office of Inspector General's initial meetings with PBMs to learn more about their business practices in advance of the Medicare drug benefit (1"The Pink Sheet" March 29, 2004, p. 15). Corrigan had been the Centers for Medicare & Medicaid Services director of program integrity before moving to HHS' OIG to fill in after the resignation of Janet Rehnquist in 2003. General Services Administration Inspector General Daniel Levinson was tapped as permanent HHS IG in July...
Medco Settlement Sets “Gold Standard” For PBMs Ahead Of Medicare Rx
Prosecutors expect that other pharmacy benefit management companies will adopt codes of conduct based on Medco's April 26 settlement with 20 state attorneys general and the U.S. Attorney in Philadelphia